Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-04 Option Award | 2024-09-06 4:23 pm | N/A 2034-09-04 | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer | 33,920 | $0 | 33,920 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 5:41 pm | N/A 2024-03-01 | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer | 965,435 | $0 | 965,435 (Direct) | View |
| 2024-02-28 Option Award | 2024-02-28 5:32 pm | N/A 2030-12-01 | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer | 421,100 | $0 | 421,100 (Direct) | View |
| 2024-02-27 Disposition | 2024-02-28 5:32 pm | 2021-01-01 2030-12-01 | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer | 854,250 | $0 | 421,100 (Direct) | View |
| 2023-10-25 Option Award | 2023-10-27 4:14 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer | 610,277 | $0.7568 | 2,425,771 (Direct) | View |
| 2023-10-25 Option Award | 2023-10-27 4:14 pm | 2023-10-25 2030-10-25 | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer | 305,138 | $0.125 | 2,425,771 (Direct) | View |
| 2023-09-08 Option Award | 2023-09-12 4:05 pm | N/A 2033-09-08 | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-17 4:09 pm | N/A 2033-03-15 | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer | 242,500 | $0 | 242,500 (Direct) | View |
| 2022-07-07 Option Award | 2022-07-11 4:13 pm | N/A 2032-07-07 | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer | 161,700 | $0 | 161,700 (Direct) | View |
| 2022-02-04 Option Award | 2022-02-08 4:09 pm | N/A 2032-02-04 | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer | 404,250 | $0 | 404,250 (Direct) | View |
| 2020-12-01 Option Award | 2020-12-03 8:03 pm | N/A 2030-12-01 | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer | 450,000 | $0 | 450,000 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer | 273,058 | $0 | 1,255,815 (Indirect) | View |
Ownership | 2020-10-15 5:09 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer | 0 | $0 | 2,368,752 (Direct) | View |